Newton Aguiar - OssDsign Independent Director

OSSD Stock  SEK 9.87  0.14  1.44%   

Insider

Newton Aguiar is Independent Director of OssDsign AB since 2019.
Age 54
Tenure 5 years
Phone46 18 55 39 93
Webhttps://www.ossdsign.com

OssDsign Management Efficiency

The company has return on total asset (ROA) of (0.1967) % which means that it has lost $0.1967 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3935) %, meaning that it generated substantial loss on money invested by shareholders. OssDsign's management efficiency ratios could be used to measure how well OssDsign manages its routine affairs as well as how well it operates its assets and liabilities.
OssDsign AB has accumulated 16.45 M in total debt with debt to equity ratio (D/E) of 0.19, which may suggest the company is not taking enough advantage from borrowing. OssDsign AB has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist OssDsign until it has trouble settling it off, either with new capital or with free cash flow. So, OssDsign's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OssDsign AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OssDsign to invest in growth at high rates of return. When we think about OssDsign's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Mirjam JohanssonSpectraCure AB
N/A
Sathish SubramaniamBactiguard Holding AB
44
Johanna TulkkiSenzime AB
53
Anders GoranssonBactiguard Holding AB
52
Charlotte WalldalXvivo Perfusion AB
56
Kristoffer NordstromXvivo Perfusion AB
38
Johan FolkungerSpectraCure AB
55
Slavoljub GrujicicSenzime AB
53
Michael NsstrmEpisurf Medical AB
34
Lena BScXvivo Perfusion AB
58
Henrik LjungSpectraCure AB
65
Peter RadqvistBactiguard Holding AB
56
Carin JakobsonBactiguard Holding AB
49
Johan HolmstromXvivo Perfusion AB
53
Beata LihammarEpisurf Medical AB
N/A
Stephen CaswellEpisurf Medical AB
42
Johannes SwartlingSpectraCure AB
51
Stefan GrassBactiguard Holding AB
51
Patrick JamnikEpisurf Medical AB
40
Katrin GisselfaltXvivo Perfusion AB
54
Veronica WallinEpisurf Medical AB
37
OssDsign AB designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden. OssDsign is traded on Stockholm Stock Exchange in Sweden. OssDsign AB (OSSD) is traded on Stockholm Exchange in Sweden and employs 48 people.

Management Performance

OssDsign AB Leadership Team

Elected by the shareholders, the OssDsign's board of directors comprises two types of representatives: OssDsign inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OssDsign. The board's role is to monitor OssDsign's management team and ensure that shareholders' interests are well served. OssDsign's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OssDsign's outside directors are responsible for providing unbiased perspectives on the board's policies.
Henrik Hjort, Director of Marketing & Business Development
Newton Aguiar, Independent Director
Rick Thomas, Vice President Commercial Operations
Kajsa Bjorklund, Director of Technical Operations
Anders Qvarnstrom, Independent Director
Viktor Drvota, Director
Sofia Sjovall, VP HR
Claes Lindblad, Chief Financial Officer
Morten Henneveld, Chief Officer
Stephane Corp, VP Marketing
Anders Lundqvist, Chief Executive Officer
Hakan Engqvist, Director
Kajsa Bjrklund, VP RD
Anders Svensson, Chief Officer
Hkan Engqvist, Cofounder Director
Simon Cartmell, Independent Chairman of the Board
Malin Kylberg, Quality Assurance Director
Ulrik Birgersson, Director Clinical Engineering

OssDsign Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OssDsign a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for OssDsign Stock Analysis

When running OssDsign's price analysis, check to measure OssDsign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OssDsign is operating at the current time. Most of OssDsign's value examination focuses on studying past and present price action to predict the probability of OssDsign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OssDsign's price. Additionally, you may evaluate how the addition of OssDsign to your portfolios can decrease your overall portfolio volatility.